EKF Diagnostics Holdings PLC
LSE:EKF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Contemporary Amperex Technology Co Ltd
SZSE:300750
|
CN |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (10.8), the stock would be worth GBX28.08 (15% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.4 | GBX24.5 |
0%
|
| 3-Year Average | 10.8 | GBX28.08 |
+15%
|
| 5-Year Average | 12.5 | GBX32.46 |
+32%
|
| Industry Average | 0 | GBX0.08 |
-100%
|
| Country Average | 0 | GBX0.07 |
-100%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
106.3m GBP | 9.4 | 50.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170B USD | 54.3 | 59.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
160.6B USD | 16.7 | 25.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.1B USD | 27 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 17.3 | 23.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
97.4B USD | 22.5 | 32 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 15.6 | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 28 | 45.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 38.4 | 42.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 17.5 | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 16.2 | 21.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 2 105.8 |
Other Multiples
EKF Diagnostics Holdings PLC
Glance View
EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. The company operates in Germany, the United States, Russia and the United Kingdom.
